LYLLANA .075 mg/d
Estradiol · PATCH, EXTENDED RELEASE · Amneal Pharmaceuticals LLC
No Recall HistoryCurrently in Shortage
Plain English
LYLLANA is a patch, extended release containing estradiol at .075 mg/d, taken transdermal. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- LYLLANA
- Generic Name
- Estradiol
- NDC Code (Product)
65162-150- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- .075 mg/d
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- ANDA211396
- Drug Class
- Estrogen [EPC]
- Marketing Start
- 09/30/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is LYLLANA used for?
LYLLANA contains Estradiol. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is LYLLANA a controlled substance?
LYLLANA is not classified as a controlled substance by the DEA.
What is the generic name for LYLLANA?
The generic name for LYLLANA is Estradiol. There are 12 other brand versions of Estradiol.
What is the NDC code for LYLLANA .075 mg/d?
The NDC (National Drug Code) for LYLLANA .075 mg/d is 65162-150, listed by Amneal Pharmaceuticals LLC.